XTX Topco’s Cogent Biosciences COGT Stock Holding History

XTX Topco’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50,470	Closed	-$1.94M	–	4213
2026 Q1	$1.94M	Buy	+50,470	New	+$1.86M	0.03%	861
2025 Q4	–	Sell	-37,831	Closed	-$543K	–	3381
2025 Q3	$543K	Sell	37,831 -78,658	-68%	-$932K	0.03%	1007
2025 Q2	$836K	Buy	116,489 +95,417	+453%	+$529K	0.03%	777
2025 Q1	$126K	Sell	21,072 -37,488	-64%	-$294K	0.01%	1818
2024 Q4	$457K	Buy	+58,560	New	+$584K	0.04%	841
2024 Q2	–	Sell	-32,851	Closed	-$221K	–	1960
2024 Q1	$221K	Sell	32,851 -50,573	-61%	-$313K	0.03%	1093
2023 Q4	$491K	Buy	+83,424	New	+$639K	0.11%	274

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

XTX Topco's COGT Position: Q2 2026 in Review

XTX Topco sold out of Cogent Biosciences (COGT) in Q2 2026, closing a stake of 50,470 shares — an estimated $1.94M sold.

XTX Topco first reported a position in COGT in Q4 2023 and held it in 7 quarters. The position peaked at $1.94M in Q1 2026. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

XTX Topco reported no remaining Cogent Biosciences position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 50,470 Cogent Biosciences shares in Q2 2026, an estimated $1.94M.
XTX Topco first reported a position in Cogent Biosciences in Q4 2023 and held it in 7 quarters.
XTX Topco's Cogent Biosciences position peaked at $1.94M in Q1 2026.
323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.